Spending on pharmaceuticals is a large proportion of expenses on health, representing 5-50% of total health spending in low-and middle-income countries. Accurate data on pharmaceutical spending […]
Read MoreCôte d’Ivoire, like many other countries, is grappling with high rates of health care–associated infections (HCAI) and antimicrobial resistance (AMR). Strong drug and therapeutic committees (DTCs) […]
Read MoreThis report summarizes the MTaPS’ strategic approach, key achievements, and results in Indonesia to strengthen evidence-based decision-making for resource allocation to health technologies and promote transparency […]
Read More